Axsome Therapeutics (AXSM) Dip Draws Investor Attention As Pipeline And Revenue Growth Accelerate
Axsome Therapeutics (NASDAQ: AXSM) has built a compelling track record in the neuroscience space, targeting conditions tied to central nervous system operations including depression, migraine, and narcolepsy. The stock climbed 180% over
